Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
Gargiulo L, Ibba L, Malagoli P, Angileri RG, Bardazzi F, Bernardini N, Burlando M, Carrera CG, Chiricozzi A, Dapavo P, Dini V, Fabbrocini G, Gaiani FM, Galluzzo M, Giofré C, Guarneri C, Loconsole F, Malara G, Marcelli L, Megna M, Piaserico S, Talamonti M, Costanzo A, Narcisi A.
Gargiulo L, et al. Among authors: ibba l.
J Eur Acad Dermatol Venereol. 2023 May;37(5):1017-1027. doi: 10.1111/jdv.18913. Epub 2023 Feb 8.
J Eur Acad Dermatol Venereol. 2023.
PMID: 36695061